- Allergy Immunology
- Anti-Infective
- Cardiology
- Dermatology
- Endocrinology #1
- Endocrinology #2
- Gastroenterology
- General Neurology #1
- General Neurology #2
- IVIG Dermatology
- IVIG Immunology
- IVIG Neurology
- IVIG Rheumatology
- Nephrology
- Neurology – Multiple Sclerosis
- Ophthalmology
- Osteoporosis
- Pulmonology
- Rheumatology #1
- Rheumatology #2
- Rheumatology #3
- Wellness
DRUG NAMES
About Actemra:
Actemra (tocilizumab) is used to treat moderate-to-severe rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). It is also used to treat giant cell arteritis, systemic sclerosis-associated interstitial lung disease, and cytokine release syndrome. Though it has not been approved by the Food and Drug Administration for use outside the hospital, in June 2021, the FDA began allowing tocilizumab to be used to treat coronavirus disease in human studies, and for emergency use.
Getting Your Infusion:
Actemra is usually administered once every 4 weeks for RA, more frequently for other diagnoses. Most Actemra infusions are intravenous, although sometimes Actemra is injected subcutaneously. Each intravenous infusion takes about an hour.
Visit Website
Prescribing Information
About Adakveo:
Adakveo (crizanlizumab-tmca) is used in people with sickle cell disease to help reduce how often pain crises, also known as “vaso-occlusive crises,” happen. Vaso-occlusive crises (VOCs) occur when micro circulation is obstructed by “sickled” red blood cells. Adakveo works by binding to P-selectin, a protein that plays a central role in cellular interactions that can lead to vaso-occlusion. In its initial study, Adakveo was shown to reduce VOCs by about 45%.
Getting Your Infusion:
Adakveo is given every 4 weeks after two starter doses. Each intravenous infusion takes about 30 minutes.
Visit Website
Prescribing Information
About Aduhelm:
Aduhelm (aducanumab) treats Alzheimer’s disease by helping to remove amyloid, a protein that can build up in the brain. Aduhelm is not a cure, and it is not for all people with memory loss. Aduhelm is intended only for patients with mild cognitive impairment, defined as a mild decrease in memory and/or thinking that occurs daily but does not yet affect functioning. Aduhelm’s approval by the US Food and Drug Administration in June 2021 was controversial, and some providers have chosen not to administer the drug. In addition, not all insurance plans will cover this drug.
SUBTITLE:
Aduhelm is administered once every 4 weeks. Each intravenous infusion takes about an hour. Your doctor will order an MRI before we begin treatment and will closely monitor your progress while you are receiving Aduhelm. This may include additional MRIs and other testing.
Visit Website
Prescribing Information
About Aralast NP:
Aralast NP (alpha 1-antitrypsin inhibitor) is a peptide isolated and purified from donor plasma. It is used to treat adults with lung disease (emphysema) caused by severe Alpha1 Antitrypsin (AAT) deficiency. The Alpha1 protein circulates in the bloodstream and works to protect the lungs from inflammation due to infection or inhaled irritants, such as tobacco smoke. Alpha1 deficiency is an inherited disorder in which a genetic mutation impacts the body’s ability to produce sufficient levels of the Alpha1 protein. Glassia, Prolastin-C, and Zemaira are related medicines with minor chemical differences associated with the purification method.
Getting Your Infusion:
Aralast NP is given weekly by intravenous infusion. Each infusion takes 15 to 30 minutes.
Visit Website
Prescribing Information
About Avsola:
Avsola (infliximab-axxq) is used to treat certain types of arthritis (Rheumatoid Arthritis (RA) and psoriatic arthritis), certain bowel diseases (Crohn’s disease and Ulcerative Colitis (UC)), as well as plaque psoriasis and ankylosing spondylitis (an inflammatory disease that, over time, can cause some of the bones in the spine to fuse). In these inflammatory conditions, your immune system becomes overactive and produces excess amounts of a protein called TNF-alpha (tumor necrosis factor alpha), which causes your immune system to attack healthy cells. Avsola blocks the action of TNF-alpha, preventing inflammation. Avsola is biosimilar to Remicade (Jannsen), the orginal forumlation of infliximab. Other Remicade biosimilars include Inflectra (Pfizer) and Renflexis (Merck).
Getting Your Infusion:
Avsola is administered by intravenous infusion every eight weeks (every 6 weeks for ankylosing spondylitis) after an induction regimen that includes three doses over six weeks. Each infusion takes about two hours. Your doctor may prescribe premedication with an antihistamine, acetaminophen, and/or corticosteroid along with your Avsola infusion.
Visit Website
Prescribing Information
About Aranesp:
What is Aranesp? Aranesp is a man-made form of the protein human erythropoietin that is given to reduce or avoid the need for red blood cell transfusions. Aranesp stimulates your bone marrow to make more red blood cells. Having more red blood cells raises your hemoglobin level.
Getting Your Infusion:
Visit Website
Prescribing Information
About Benlysta:
Benlysta (belimumab) is used to treat active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis (lupus-related kidney inflammation) in people who are receiving other lupus medicines. In lupus, the immune system produces harmful antibodies that attack the body’s own tissues. Benlysta targets a type of white blood cell, called B-cells, that produce these antibodies. Benlysta works by binding to the protien BLyS that is necessary for B-cells to grow.
Getting Your Infusion:
Benlysta is usually administered once every 4 weeks as a one-hour infusion, though it can alo be given subcutaneously, in the abdomen or thigh. Subcutaneous injections are generally given once each week.
Visit Website
Prescribing Information
About Bivigam:
BIVIGAM [Immune Globulin Intravenous (Human), 10% Liquid] is indicated for the treatment of primary humoral immunodeficiency (PI). This includes, but is not limited to, the humoral immune defect in common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
Getting Your Infusion:
BIVIGAM is usually administered once every 3 to 4 weeks as a 2-3 hour infusion.
Visit Website
Prescribing Information
About Cerezyme:
Cerezyme® (imiglucerase) for injection is indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions: anemia (low red blood cell count), thrombocytopenia (low blood platelet count), bone disease, or hepatomegaly or splenomegaly (enlarged liver or spleen). Cerezyme is designed to reduce the build-up of GL-1 in people who do not have enough of the natural enzyme to keep up with their bodies’ production. Cerezyme acts like glucocerebrosidase (the body’s natural enzyme), breaking down GL-1 into its more basic elements, glucose and ceramide, that can be naturally removed from the body.
Getting Your Infusion:
Cerezyme is administered by infusion over 1 to 2 hours with a frequency ranging from several times a week to every 2 weeks.
Visit Website
Prescribing Information
About Cimzia:
CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used in adults to:
Lessen the signs and symptoms of moderately to severely active Crohn’s disease (CD) in adults who have not been helped enough by usual treatments
Treat moderately to severely active rheumatoid arthritis (RA)
Treat active psoriatic arthritis (PsA)
Treat active ankylosing spondylitis (AS)
Treat active non-radiographic axial spondyloarthritis (nr-axSpA) with measures of inflammation
Treat moderate to severe plaque psoriasis (PsO) in adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills)
Visit Website
Prescribing Information
About Cinqair:
Cinqair is a monoclonal antibody that affects the actions of the body’s immune system. Reslizumab works by reducing levels of a certain type of white blood cell that may contribute to the symptoms of asthma.
Getting Your Infusion:
Cinqair is given as an infusion, usually once every 4 weeks. Each infusion 20 to 50 minutes to complete.
Visit Website
Prescribing Information
About Cosentyx:
Cosentyx is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation.
Cosentyx is used to treat adults and children 6 years of age and older with moderate to severe plaque psoriasis (raised, silvery flaking of the skin) that involves large areas or many areas of the body, and who may benefit from using injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light alone or with systemic therapy).
Cosentyx is used to treat adults and children 2 years of age and older with active psoriatic arthritis.
Cosentyx is used to treat adults with active ankylosing spondylitis, and active non-radiographic axial spondyloarthritis.
Cosentyx is also used to treat children and adolescents 4 years of age and older with active enthesitis-related arthritis.
Getting Your Infusion:
Cosentyx is injected under the skin, usually for 4 weeks as a loading dose then every 4 weeks thereafter.
Visit Website
Prescribing Information
About Crysvita:
CRYSVITA is a drug for the treatment of a genetic form of rickets called X-linked hypophosphatemia, in patients 1 year of age and older. X-linked hypophosphatemia (XLH) is a rare inherited disorder characterized by low levels of phosphate in the blood which causes soft, weak bones (rickets).
Visit Website
Prescribing Information
About Cubicin:
Cubicin is an antibiotic that fights bacteria in the body.
Cubicin is used to treat bacterial infections of the skin and underlying tissues, and infections that have entered the bloodstream.
Cubicin is used for complicated infections, including MRSA or “super bug” infections. MRSA stands for methicillin-resistant Staphylococcus aureus.
Getting Your Infusion:
Cubicin is given as an infusion that can take 2 to 30 minutes to complete.
Visit Website
Prescribing Information
About Cuvitru:
Cuvitru (for injection under the skin) is used to treat primary immunodeficiency diseases.
Cuvitru is also used to treat chronic inflammatory demyelinating polyneuropathy (an autoimmune disorder in which the immune system attacks the nerves, causing muscle weakness and numbness)
Getting Your Infusion:
Cuvitru is injected under the skin using an infusion pump. The medicine enters the body through a catheter placed under your skin.
Visit Website
Prescribing Information
About Dalvance:
Dalvance is an injectable intravenous (IV) antibiotic that is used to treat severe bacterial skin infections. It works by stopping the growth of bacteria.
Visit Website
Prescribing Information
About Dupixent:
Atopic Dermatitis: DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Visit Website
Prescribing Information
About Elaprase:
Elaprase is used to treat patients with Hunter syndrome. It is designed for long-term use. Hunter syndrome, which is also known as mucopolysaccharidosis II, is a rare, inherited disease that primarily affects male patients. Patients with Hunter syndrome do not produce an enzyme called iduronate-2-sulfatase.
Visit Website
Prescribing Information
About Elelyso:
Elelyso is designed to replace the missing or defective enzyme, glucocerebrosidase, in people with Type 1 Gaucher disease.
Visit Website
Prescribing Information
About Enbrel:
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.
Visit Website
Prescribing Information
About Entyvio:
Entyvio (vedolizumab) is used to treat moderate to severe ulcerative colitis (UC) and moderate to severe Crohn’s Disease. Entyvio treats active disease and may help keep UC or Crohn’s symptoms under control long term. It may also reduce the need for steroid medicines in helping to control symptoms long term. Entyvio is usually given after other treatments have failed. Entyvio works by preventing an excess of white blood cells from entering into the GI tract. This helps to control inflammation and symptoms of ulcerative colitis and Crohn’s disease.
Getting Your Infusion:
Entyvio is administered by intravenous infusion every eight weeks, after two starter doses in the first six weeks. Each infusion takes about 30 minutes.
Visit Website
Prescribing Information
About Evenity:
EVENITY® is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture or who cannot use another osteoporosis medicine or other osteoporosis medicines did not work well.
Visit Website
Prescribing Information
About Fabrazyme:
Fabrazyme is indicated for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease. One goal in the treatment of Fabry disease is to clear and prevent future buildup of a fatty substance called GL-3, which can accumulate in key organs and cause organ damage.
Visit Website
Prescribing Information
About Fasenra:
FASENRA is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people 12 years and older whose asthma is not controlled with their current asthma medicines.
Visit Website
Prescribing Information
About Feraheme:
Feraheme is a prescription medicine used to treat iron-deficiency anemia in adults with chronic kidney disease. Iron-deficiency anemia is a condition in which there is a lower than normal number of red blood cells because of too little iron. Feraheme is in a class of medicines called iron replacement products.
Visit Website
Prescribing Information
About Gammagard:
GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older and given in a vein to treat multifocal motor neuropathy (MMN) in adults.
Visit Website
Prescribing Information
About Gammaked:
GAMMAKED is an immune globulin (IG) injection approved to treat chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse, primary humoral immunodeficiency (PI) in patients 2 years of age and older, and idiopathic thrombocytopenic purpura (ITP) in adults and children to raise platelet counts to prevent bleeding or to allow a patient with ITP to undergo surgery.
Getting Your Infusion:
GAMMAKED may be administered either intravenously or subcutaneously for the treatment of PI. GAMMAKED may only be administered intravenously for the treatment of CIDP and ITP.
Visit Website
Prescribing Information
About Gamunex-C:
GAMUNEX®-C (immune globulin injection [human], 10% caprylate/chromatography purified) is approved to treat primary humoral immunodeficiency disease (PIDD) in patients 2 years of age and older. If you have PIDD, you may take GAMUNEX-C under the skin (subcutaneously) or in a vein (intravenously).
Visit Website
Prescribing Information
About Glassia:
Glassia (alpha 1-antitrypsin inhibitor) is a peptide isolated from donor plasma and purified. It is used to treat adults with lung disease (emphysema) caused by severe Alpha1 Antitrypsin (AAT) deficiency. The Alpha1 protein circulates in the bloodstream and works to protect the lungs from inflammation due to infection or inhaled irritants, such as tobacco smoke. Alpha1 deficiency is an inherited disorder in which a genetic mutation impacts the body’s ability to produce sufficient levels of the Alpha1 protein. Aralast NP, Prolastin-C, and Zemaira are related medicines with minor chemical differences associated with the purification method.
Getting Your Infusion:
Glassia is given weekly by intravenous infusion. Each infusion takes 15 to 30 minutes.
Visit Website
Prescribing Information
About Hizentra:
What is Hizentra and what is it used for? Hizentra is used in patients whose blood does not contain enough antibodies (proteins that help the body to fight infections and other diseases), also known as immunoglobulins.
Visit Website
Prescribing Information
About Humira:
Humira (Adalimumab) is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa).
Visit Website
Prescribing Information
About Ilaris:
Treatment of Still’s disease, and periodic fever syndromes such as: Cryopyrin-associated periodic syndromes (e.g., familial cold autoinflammatory syndrome, Muckle-Wells syndrome)
Visit Website
Prescribing Information
About Inflectra:
Inflectra (infliximab-dyyb) is used to treat certain types of arthritis (Rheumatoid Arthritis (RA) and psoriatic arthritis), certain bowel diseases (Crohn’s disease and Ulcerative Colitis (UC)), as well as plaque psoriasis and ankylosing spondylitis (an inflammatory disease that, over time, can cause some of the bones in the spine to fuse). In these inflammatory conditions, your immune system becomes overactive and produces excess amounts of a protein called TNF-alpha (tumor necrosis factor alpha), which causes your immune system to attack healthy cells. Inflectra blocks the action of TNF-alpha, preventing inflammation. Inflectra is biosimilar to Remicade (Jannsen), the orginal forumlation of infliximab. Other Remicade biosimilars include Avsola (Amgen) and Renflexis (Merck).
Getting Your Infusion:
Inflectra is administered by intravenous infusion every eight weeks (every 6 weeks for ankylosing spondylitis) after an induction regimen that includes three doses over six weeks. Each infusion takes about two hours. Your doctor may prescribe premedication with an antihistamine, acetaminophen, and/or corticosteroid along with your Inflectra infusion.
Visit Website
Prescribing Information
About Ilumya:
ILUMYA is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).
Visit Website
Prescribing Information
About Injectafer:
Injectafer is injected into your vein to treat iron deficiency anemia in adults and pediatric patients 1 year of age and older. Injectafer should be used only if you have not responded well to treatment with oral iron, or if you are intolerant to oral iron treatment.
Visit Website
Prescribing Information
About Invanz:
Ertapenem (Invanz) is a carbapenem antibiotic that treats serious bacterial infections, including some that are due to drug-resistant bacteria. It’s available only in injection form.
Visit Website
Prescribing Information
About Invega Sustenna:
INVEGA SUSTENNA® is a prescription medicine given by injection by a healthcare professional. INVEGA SUSTENNA® is used to treat schizophrenia in adults.
Visit Website
Prescribing Information
About Kanuma:
Kanuma is a medicine used to treat patients of all ages with lysosomal acid lipase deficiency. This is an inherited disease caused by the lack of an enzyme called lysosomal acid lipase, which is needed to break down fats within cells.
Visit Website
Prescribing Information
About Kimyrsa:
Both KIMYRSA® and ORBACTIV® are oritavancin products that are indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused or suspected to be caused by susceptible isolates of the following gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible [MSSA] and methicillin-resistant [MRSA] isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus anginosus group (includes S. anginosus, S. intermedius, and S. constellatus), and Enterococcus faecalis (vancomycin-susceptible isolates only).
Visit Website
Prescribing Information
About Krystexxa:
Krystexxa (Pegloticase) is a prescription medicine used in adults to help reduce the signs and symptoms of gout that are not controlled by other treatments used to lower blood uric acid levels in adults with gout. Uric acid comes from substances called purines.
Visit Website
Prescribing Information
About Lemtrada:
Lemtrada is approved by the FDA for the treatment of relapsing forms of multiple sclerosis, to include relapsing remitting disease and active secondary progressive disease, in adults.
Visit Website
Prescribing Information
About Leqvio:
LEQVIO (inclisiran) is an injectable prescription medicine used along with diet and other lipid-lowering medicines in adults who need additional lowering of “bad” cholesterol (LDL-C) and have known cardiovascular disease and/or heterozygous familial hypercholesterolemia (HeFH), an inherited condition that causes high levels of LDL-C. It is not known if LEQVIO can decrease problems related to high cholesterol, such as heart attacks or stroke.
Visit Website
Prescribing Information
About Lumizyme:
Lumizyme ® (alglucosidase alfa) is a medication that replaces a missing or deficient enzyme in people with Pompe disease. If you have Pompe disease, ask your healthcare provider if Lumizyme is an appropriate treatment for you.
Visit Website
Prescribing Information
About Mycamine:
This medication is used to treat a variety of fungal infections. It is also used to prevent fungal infections in patients who are having a stem cell transplant. Micafungin belongs to a class of drugs known as echinocandins. It works by stopping the growth of fungi.
Visit Website
Prescribing Information
About Nucala:
NUCALA is an add-on, prescription maintenance treatment for patients 6 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems. Do not use NUCALA if you are allergic to mepolizumab or any of the ingredients in NUCALA. Do not use to treat sudden breathing problems.
Visit Website
Prescribing Information
About Orbactiv:
Both KIMYRSA® and ORBACTIV® are oritavancin products that are indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused or suspected to be caused by susceptible isolates of the following gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible [MSSA] and methicillin-resistant [MRSA] isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus anginosus group (includes S. anginosus, S. intermedius, and S. constellatus), and Enterococcus faecalis (vancomycin-susceptible isolates only).
Visit Website
Prescribing Information
About Orencia:
ORENCIA is used to reduce signs and symptoms of moderate to severe Rheumatoid Arthritis in adults 18 years and older. Taking ORENCIA may prevent further damage to your bones and joints, and may help your ability to perform daily activities.
Visit Website
Prescribing Information
About Ocrevus:
Ocrevus (ocrelizumab) is used to treat relapsing or primary progressive forms of multiple sclerosis (MS). Ocrevus is a monoclonal antibody that targets CD20 positive B lymphocytes (a type of white blood cell), which contribute to nerve damage in MS. This may help to protect healthy cells from damage. Ocrevus is usually administered by intravenous infusion every six months, after a starter dose that is split into two separate infusions, two weeks apart. Each infusion takes from 2-1/2 to 4 hours. Patients are routinely given other medications at the same time to help prevent certain side effects of the drug.
Visit Website
Prescribing Information
About Octogam 10%:
This medication is used to strengthen the body’s natural defense system (immune system) to lower the risk of infection in persons with a weakened immune system. This medication is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections.
Visit Website
Prescribing Information
About Onpattro:
ONPATTRO is a prescription medicine for adults that treats the polyneuropathy caused by an illness called hereditary ATTR (hATTR) amyloidosis.
Visit Website
Prescribing Information
About Privigen:
Privigen®, Immune Globulin Intravenous (Human), 10% Liquid, is approved to: Treat types of primary immunodeficiency (PI). Raise platelet counts in patients over 15 with chronic immune thrombocytopenic purpura (ITP). Treat chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
Visit Website
Prescribing Information
About Prolastin-C:
Prolastin C (alpha 1-antitrypsin inhibitor) is a peptide isolated from donor plasma and purified. It is used to treat adults with lung disease (emphysema) caused by severe Alpha1 Antitrypsin (AAT) deficiency. The Alpha1 protein circulates in the bloodstream and works to protect the lungs from inflammation due to infection or inhaled irritants, such as tobacco smoke. Alpha1 deficiency is an inherited disorder in which a genetic mutation impacts the body’s ability to produce sufficient levels of the Alpha1 protein. Aralast NP, Glassia, and Zemaira are related medicines with minor chemical differences associated with the purification method.
Getting Your Infusion:
Prolastin C is given weekly by intravenous infusion. Each infusion takes 15 to 30 minutes.
Visit Website
Prescribing Information
About Prolia:
Prolia is a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. The Prolia brand of denosumab is used to treat osteoporosis in postmenopausal women who have high risk of bone fracture. Prolia is used to increase bone mass in men with osteoporosis with a high risk of bone fracture, and in women and men with a high risk of bone fracture caused by receiving treatments for certain types of cancer. Prolia is also used to treat glucocorticoid-induced osteoporosis in men and women at high risk of bone fracture.
Getting Your Infusion:
Prolia is given once every six months
Visit Website
Prescribing Information
About Qutenza:
QUTENZA® (capsaicin) 8% topical system is indicated in adults for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and for neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet.
Visit Website
Prescribing Information
About Radicava:
Radicava works by relieving the effects of oxidative stress, which may be related to the death of motor neurons (nerve cells) in people with amyotrophic lateral sclerosis (ALS). Keeping motor neurons healthy may help to preserve muscle function. Radicava is used to treat amyotrophic lateral sclerosis.
Visit Website
Prescribing Information
About Reclast:
ZOLEDRONIC ACID (Reclast) Zoledronic acid is a bisphosphonate prescribed to prevent or treat osteoporosis or Paget’s disease. Unlike other common bisphosphonates that are taken by mouth, Reclast bypasses the stomach because it is an infusion into the bloodstream. Bone is a living tissue constantly being remodeled.
Visit Website
Prescribing Information
About Remicade:
Remicade (infliximab) is used to treat certain types of arthritis (Rheumatoid Arthritis (RA) and psoriatic arthritis), certain bowel diseases (Crohn’s disease and Ulcerative Colitis (UC)), as well as plaque psoriasis and ankylosing spondylitis (an inflammatory disease that, over time, can cause some of the bones in the spine to fuse). In these inflammatory conditions, your immune system becomes overactive and produces excess amounts of a protein called TNF-alpha (tumor necrosis factor alpha), which causes your immune system to attack healthy cells. Remicade blocks the action of TNF-alpha, preventing inflammation. In recent years, a number of infliximab biosimilars have been introduced, including Avsola (Amgen), Inflectra (Pfizer), and Renflexis (Merck), which are often prescribed instead of original Remicade.
Getting Your Infusion:
Remicade is administered by intravenous infusion every eight weeks (every 6 weeks for ankylosing spondylitis) after an induction regimen that includes three doses over six weeks. Each infusion takes about two hours. Your doctor may prescribe premedication with an antihistamine, acetaminophen, and/or corticosteroid along with your Remicade infusion.
Visit Website
Prescribing Information
About Renflexis:
Renflexis (infliximab-abda) is used to treat certain types of arthritis (Rheumatoid Arthritis (RA) and psoriatic arthritis), certain bowel diseases (Crohn’s disease and Ulcerative Colitis (UC)), as well as plaque psoriasis and ankylosing spondylitis (an inflammatory disease that, over time, can cause some of the bones in the spine to fuse). In these inflammatory conditions, your immune system becomes overactive and produces excess amounts of a protein called TNF-alpha (tumor necrosis factor alpha), which causes your immune system to attack healthy cells. Renflexis blocks the action of TNF-alpha, preventing inflammation. Renflexis is biosimilar to Remicade (Jannsen), the orginal forumlation of infliximab. Other Remicade biosimilars include Avsola (Amgen) and Inflectra (Pfizer).
Getting Your Infusion:
Renflexis is administered by intravenous infusion every eight weeks (every 6 weeks for ankylosing spondylitis) after an induction regimen that includes three doses over six weeks. Each infusion takes about two hours. Your doctor may prescribe premedication with an antihistamine, acetaminophen, and/or corticosteroid along with your Renflexis infusion.
Visit Website
Prescribing Information
About Rocephin:
Rocephin is a cephalosporin (SEF a low spor in) antibiotic. . It works by fighting bacteria in your body. Rocephin is used to treat many kinds of bacterial infections, including severe or life-threatening forms such as E. coli, pneumonia, or meningitis. Rocephin is also used to prevent infection in people having certain types of surgery.
Visit Website
Prescribing Information
About Simponi Aria:
SIMPONI ARIA® is a prescription medicine used to treat: Moderate to severe rheumatoid arthritis (RA) in adults, used in combination with methotrexate. Active psoriatic arthritis (PsA) in people 2 years of age and older. Active ankylosing spondylitis (AS) in adults.
Visit Website
Prescribing Information
About Skyrizi:
Skyrizi (also known by its generic name risankizumab-rzaa) was approved by the FDA in April 2019 for the treatment of moderate-to-severe plaque psoriasis in adults.
Visit Website
Prescribing Information
About Soliris:
SOLIRIS is a prescription medicine used to treat adults with a disease called generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. It is not known if SOLIRIS is safe and effective in children with gMG.
Visit Website
Prescribing Information
About Solu-Medrol:
Solu-MEDROL is a steroid that prevents the release of substances in the body that cause inflammation. Solu-MEDROL is used to treat many different inflammatory conditions such as arthritis, lupus, psoriasis, ulcerative colitis, allergic disorders, gland (endocrine) disorders, and conditions that affect the skin, eyes, lungs, stomach, nervous system, or blood cells.
Visit Website
Prescribing Information
About Stelara:
Ustekinumab (Stelara) is a biologic medication used to lower inflammation and help adult patients and patients six years or older with moderate to severe plaque psoriasis, adult patients with psoriatic arthritis, and adult patients with moderate to severe Crohn’s Disease and Ulcerative Colitis.
Visit Website
Prescribing Information
About Tepezza:
TEPEZZA is a drug for the treatment of thyroid eye disease. Thyroid eye disease is a rare, autoimmune disease characterized by proptosis (a condition where the eyes are pushed forward and bulge outward) leading to eye pain, double vision and difficulty closing the eyelid.
Visit Website
Prescribing Information
About Tezspire:
TEZSPIRE is a prescription medicine used with other asthma medicines for the maintenance treatment of severe asthma in people 12 years of age and older whose asthma is not controlled with their current asthma medicine. TEZSPIRE helps prevent severe asthma attacks (exacerbations) and can improve your breathing.
Visit Website
Prescribing Information
About Tysabri:
Tysabri (natalizumab) is used to treat relapsing and secondary progressive forms of multiple sclerosis (MS). It is also prescribed to treat moderately to severely active Crohn’s disease in patients for whom other treatments haven’t worked. Tysabri is a a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect other, healthy cells from damage. In rare cases, Tysabri can cause a serious brain infection called PML that can lead to disability or death. In 2005, this led the manufacturer to take Tysabri off the market. Tysabri was reintroduced after the manufacturer developed a program to register patients and follow up regularly to find any possible cases of PML as soon as possible.
Getting Your Infusion:
Tysabri is administered by intravenous infusion every four weeks. Each infusion takes about an hour.
Visit Website
Prescribing Information
About Ultomiris:
Ultomiris (ravulizumab-cwvz) has been approved in the US for the treatment of adult patients with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive, which represents 80% of people living with the disease.
Visit Website
Prescribing Information
About Uplizna:
UPLIZNA is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive.
Visit Website
Prescribing Information
About Vancomycin:
Vancomycin is used to treat infections caused by bacteria. It works by killing bacteria or preventing their growth. Vancomycin will not work for colds, flu, or other virus infections. Vancomycin injection is also used to treat serious infections for which other medicines may not work.
Visit Website
Prescribing Information
About Venofer:
Venofer® (iron sucrose) injection, USP is an established and effective treatment for chronic kidney disease (CKD) patients experiencing iron deficiency anemia (IDA). Venofer provides IV iron therapy for the treatment of IDA in adult and pediatric patients 2 years and older with CKD.
Visit Website
Prescribing Information
About Vibativ:
Vibativ is a prescription medicine used to treat the symptoms of Skin and Skin Structure Infections, and Pneumonia). Vibativ may be used alone or with other medications. Vibativ belongs to a class of drugs called Glycopeptides.
Visit Website
Prescribing Information
About Vivitrol:
Vivitrol is an extended release formulation of naltrexone, which is an opioid receptor antagonist. This medication was officially approved in 2010 by the Food and Drug Administration for the prevention of relapse to opioid dependence. It works by binding to opioid receptors in the brain for up to a one-month duration.
Visit Website
Prescribing Information
About VPRIV:
Long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.
Visit Website
Prescribing Information
About VYEPTI:
VYEPTI is indicated for the preventive treatment of migraine in adults.
Visit Website
Prescribing Information
About Vyvgart:
For adults with anti-AChR antibody positive generalized myasthenia gravis (gMG)
Visit Website
Prescribing Information
About Xolair:
Xolair is a drug that acts by binding to the IgE allergic antibody in the blood stream and hence neutralizing (blocking) its actions. The U.S. Food and Drug Administration (FDA) has approved Xolair for the treatment of patients with moderate to severe persistent asthma.
Visit Website
Prescribing Information
About Zemaira:
Zemaira (alpha 1-antitrypsin inhibitor) is a peptide isolated from donor plasma and purified. It is used to treat adults with lung disease (emphysema) caused by severe Alpha1 Antitrypsin (AAT) deficiency. The Alpha1 protein circulates in the bloodstream and works to protect the lungs from inflammation due to infection or inhaled irritants, such as tobacco smoke. Alpha1 deficiency is an inherited disorder in which a genetic mutation impacts the body’s ability to produce sufficient levels of the Alpha1 protein. Aralast NP, Glassia, and Prolastin-C are related medicines with minor chemical differences associated with the purification method.
Getting Your Infusion:
Zemaira is given weekly by intravenous infusion. Each infusion takes 15 to 30 minutes.
Visit Website
Prescribing Information
About Zinplava:
ZINPLAVA is a human monoclonal antibody that binds to Clostridium difficile toxin B, indicated to reduce recurrence of Clostridium difficile infection (CDI) in patients 18 years of age or older who are receiving antibacterial drug treatment of CDI and are at a high risk for CDI recurrence.
Visit Website
Prescribing Information
